One of the good things in HC is your comprehensive details in most of your posts.
These directors should have been ousted for showing greed and breeding inconfidence.
Jane Bell an independent director In MSB bought MSB shares when it was rock bottom low, showing confidence in the company.
In Biotron, directors and CEO are pest-like stray cats, sorry to comment like this, waited on the sideline and saw the options getting lapsed.
C14 engaged should have created an enthusiasm to get their options exercised and show the confidence. MM (Completely Effortless Operator) pretending to be running a large company selling products must be awarded with 10% of the pay she has been receving. MM's and PN's salary is not more than 10% of what they've been receiving. They will get paid in full after any deal. Paying them in full until the deal is likely to let these pests and stray cats create a colony of wortless greedy ceo and directors and staff busy breeding..... and spoiling ......
SHs demand a complete operational sructure of copperation between Biotron and C14. How is C14 getting paid? Complete analyses of the results are yet to be announced, so how is C14 going to entice a potential partner for Biotron? What should have MM let the market know about the C14, given that the analyses of the results are still be announced? Any thoughts, please, GY? Thanks in advance!
- Forums
- ASX - By Stock
- Ann: Agreement with C14 Consulting Group
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

One of the good things in HC is your comprehensive details in...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 38848316 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18281126 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 37148316 | 0.002 |
33 | 65631001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 14162401 | 23 |
0.004 | 12820969 | 17 |
0.005 | 6684000 | 5 |
0.006 | 1200000 | 2 |
0.007 | 1084188 | 2 |
Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online